Anna E. Vilgelm

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 572 citations · Full text

Life Sciences, Immunology, Oncology +17

Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial Cells

Jinxiong Wei, Toni A. Nagy, Anna E. Vilgelm et al. · Gastroenterology · 2010 · 189 citations · Full text

Medicine, Microbiology, Molecular Biology +13

PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses

Jiqing Sai, Philip Owens, Sergey V. Novitskiy et al. · Clinical Cancer Research · 2016 · 172 citations

Medicine, Oncology, Pharmacology +17

MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21

Anna E. Vilgelm, Nabil Saleh, Rebecca L. Shattuck-Brandt et al. · Science Translational Medicine · 2019 · 135 citations · Full text

Medicine, Cancer Biology, Oncology +16

Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells

Anna E. Vilgelm, Jeff S. Pawlikowski, Yan Liu et al. · Cancer Research · 2014 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17